CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
23 hedge funds and large institutions have $11.3M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
Holders
23
Holders Change
+1
Holders Change %
+4.55%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$413K |
| 2 |
AWA
2
Arete Wealth Advisors
Chicago,
Illinois
|
$322K |
| 3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$1.01M |
| 4 |
BL
4
BCWM LLC
Overland Park,
Kansas
|
$5.32M |
| 5 |
5
Morgan Stanley
New York
|
$1.01M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FAAS
26
First Allied Advisory Services
San Diego,
California
| – | -$18K | -955 | Closed |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| – | -$3K | -134 | Closed |
|
28
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$1K | -40 | Closed |
|